Global Influenza RNA Polymerase Inhibitor Market Growth (Status and Outlook) 2026-2032

August 2026 | 88 pages | ID: G1EDF73C5B68EN
LP Information

Abstracts

The global Influenza RNA Polymerase Inhibitor market size is predicted to grow from US$ 212 million in 2025 to US$ 322 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

United States market for Influenza RNA Polymerase Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Influenza RNA Polymerase Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Influenza RNA Polymerase Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Influenza RNA Polymerase Inhibitor players cover AstraZeneca, Tesaro, Merck & Co, Clovis Oncology, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Influenza RNA Polymerase Inhibitor Industry Forecast? looks at past sales and reviews total world Influenza RNA Polymerase Inhibitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Influenza RNA Polymerase Inhibitor sales for 2026 through 2032. With Influenza RNA Polymerase Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza RNA Polymerase Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global Influenza RNA Polymerase Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Influenza RNA Polymerase Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Influenza RNA Polymerase Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza RNA Polymerase Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza RNA Polymerase Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza RNA Polymerase Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• M2 Ion Channel Inhibitor
• NA Inhibitor

Segmentation by Application:

• Pharmaceutical Manufacturing
• Clinical Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Tesaro
• Merck & Co
• Clovis Oncology
• Pfizer
• GSK
• Zai Lab
• Fujifilm Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Influenza RNA Polymerase Inhibitor Market Size (2021-2032)
  2.1.2 Influenza RNA Polymerase Inhibitor Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Influenza RNA Polymerase Inhibitor by Country/Region (2021, 2025 & 2032)
2.2 Influenza RNA Polymerase Inhibitor Segment by Type
  2.2.1 M2 Ion Channel Inhibitor
  2.2.2 NA Inhibitor
  2.2.3 Influenza RNA Polymerase Inhibitor Market Size by Type
    2.2.3.1 Influenza RNA Polymerase Inhibitor Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
2.3 Influenza RNA Polymerase Inhibitor Segment by Application
  2.3.1 Pharmaceutical Manufacturing
  2.3.2 Clinical Research
  2.3.3 Others
  2.3.4 Influenza RNA Polymerase Inhibitor Market Size by Application
    2.3.4.1 Influenza RNA Polymerase Inhibitor Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)

3 INFLUENZA RNA POLYMERASE INHIBITOR MARKET SIZE BY PLAYER

3.1 Influenza RNA Polymerase Inhibitor Market Size Market Share by Player
  3.1.1 Global Influenza RNA Polymerase Inhibitor Revenue by Player (2021-2026)
  3.1.2 Global Influenza RNA Polymerase Inhibitor Revenue Market Share by Player (2021-2026)
3.2 Global Influenza RNA Polymerase Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INFLUENZA RNA POLYMERASE INHIBITOR BY REGION

4.1 Influenza RNA Polymerase Inhibitor Market Size by Region (2021-2026)
4.2 Global Influenza RNA Polymerase Inhibitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Influenza RNA Polymerase Inhibitor Market Size Growth (2021-2026)
4.4 APAC Influenza RNA Polymerase Inhibitor Market Size Growth (2021-2026)
4.5 Europe Influenza RNA Polymerase Inhibitor Market Size Growth (2021-2026)
4.6 Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Influenza RNA Polymerase Inhibitor Market Size by Country (2021-2026)
5.2 Americas Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026)
5.3 Americas Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Influenza RNA Polymerase Inhibitor Market Size by Region (2021-2026)
6.2 APAC Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026)
6.3 APAC Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Influenza RNA Polymerase Inhibitor Market Size by Country (2021-2026)
7.2 Europe Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026)
7.3 Europe Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Influenza RNA Polymerase Inhibitor by Region (2021-2026)
8.2 Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026)
8.3 Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INFLUENZA RNA POLYMERASE INHIBITOR MARKET FORECAST

10.1 Global Influenza RNA Polymerase Inhibitor Forecast by Region (2027-2032)
  10.1.1 Global Influenza RNA Polymerase Inhibitor Forecast by Region (2027-2032)
  10.1.2 Americas Influenza RNA Polymerase Inhibitor Forecast
  10.1.3 APAC Influenza RNA Polymerase Inhibitor Forecast
  10.1.4 Europe Influenza RNA Polymerase Inhibitor Forecast
  10.1.5 Middle East & Africa Influenza RNA Polymerase Inhibitor Forecast
10.2 Americas Influenza RNA Polymerase Inhibitor Forecast by Country (2027-2032)
  10.2.1 United States Market Influenza RNA Polymerase Inhibitor Forecast
  10.2.2 Canada Market Influenza RNA Polymerase Inhibitor Forecast
  10.2.3 Mexico Market Influenza RNA Polymerase Inhibitor Forecast
  10.2.4 Brazil Market Influenza RNA Polymerase Inhibitor Forecast
10.3 APAC Influenza RNA Polymerase Inhibitor Forecast by Region (2027-2032)
  10.3.1 China Influenza RNA Polymerase Inhibitor Market Forecast
  10.3.2 Japan Market Influenza RNA Polymerase Inhibitor Forecast
  10.3.3 Korea Market Influenza RNA Polymerase Inhibitor Forecast
  10.3.4 Southeast Asia Market Influenza RNA Polymerase Inhibitor Forecast
  10.3.5 India Market Influenza RNA Polymerase Inhibitor Forecast
  10.3.6 Australia Market Influenza RNA Polymerase Inhibitor Forecast
10.4 Europe Influenza RNA Polymerase Inhibitor Forecast by Country (2027-2032)
  10.4.1 Germany Market Influenza RNA Polymerase Inhibitor Forecast
  10.4.2 France Market Influenza RNA Polymerase Inhibitor Forecast
  10.4.3 UK Market Influenza RNA Polymerase Inhibitor Forecast
  10.4.4 Italy Market Influenza RNA Polymerase Inhibitor Forecast
  10.4.5 Russia Market Influenza RNA Polymerase Inhibitor Forecast
10.5 Middle East & Africa Influenza RNA Polymerase Inhibitor Forecast by Region (2027-2032)
  10.5.1 Egypt Market Influenza RNA Polymerase Inhibitor Forecast
  10.5.2 South Africa Market Influenza RNA Polymerase Inhibitor Forecast
  10.5.3 Israel Market Influenza RNA Polymerase Inhibitor Forecast
  10.5.4 Turkey Market Influenza RNA Polymerase Inhibitor Forecast
10.6 Global Influenza RNA Polymerase Inhibitor Forecast by Type (2027-2032)
10.7 Global Influenza RNA Polymerase Inhibitor Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Influenza RNA Polymerase Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Influenza RNA Polymerase Inhibitor Product Offered
  11.1.3 AstraZeneca Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 Tesaro
  11.2.1 Tesaro Company Information
  11.2.2 Tesaro Influenza RNA Polymerase Inhibitor Product Offered
  11.2.3 Tesaro Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Tesaro Main Business Overview
  11.2.5 Tesaro Latest Developments
11.3 Merck & Co
  11.3.1 Merck & Co Company Information
  11.3.2 Merck & Co Influenza RNA Polymerase Inhibitor Product Offered
  11.3.3 Merck & Co Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Merck & Co Main Business Overview
  11.3.5 Merck & Co Latest Developments
11.4 Clovis Oncology
  11.4.1 Clovis Oncology Company Information
  11.4.2 Clovis Oncology Influenza RNA Polymerase Inhibitor Product Offered
  11.4.3 Clovis Oncology Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Clovis Oncology Main Business Overview
  11.4.5 Clovis Oncology Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer Influenza RNA Polymerase Inhibitor Product Offered
  11.5.3 Pfizer Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 GSK
  11.6.1 GSK Company Information
  11.6.2 GSK Influenza RNA Polymerase Inhibitor Product Offered
  11.6.3 GSK Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 GSK Main Business Overview
  11.6.5 GSK Latest Developments
11.7 Zai Lab
  11.7.1 Zai Lab Company Information
  11.7.2 Zai Lab Influenza RNA Polymerase Inhibitor Product Offered
  11.7.3 Zai Lab Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Zai Lab Main Business Overview
  11.7.5 Zai Lab Latest Developments
11.8 Fujifilm Pharma
  11.8.1 Fujifilm Pharma Company Information
  11.8.2 Fujifilm Pharma Influenza RNA Polymerase Inhibitor Product Offered
  11.8.3 Fujifilm Pharma Influenza RNA Polymerase Inhibitor Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Fujifilm Pharma Main Business Overview
  11.8.5 Fujifilm Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Influenza RNA Polymerase Inhibitor Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Influenza RNA Polymerase Inhibitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of M2 Ion Channel Inhibitor
Table 4. Major Players of NA Inhibitor
Table 5. Influenza RNA Polymerase Inhibitor Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
Table 8. Influenza RNA Polymerase Inhibitor Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)
Table 11. Global Influenza RNA Polymerase Inhibitor Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Influenza RNA Polymerase Inhibitor Revenue Market Share by Player (2021-2026)
Table 13. Influenza RNA Polymerase Inhibitor Key Players Head office and Products Offered
Table 14. Influenza RNA Polymerase Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Influenza RNA Polymerase Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Region (2021-2026)
Table 19. Global Influenza RNA Polymerase Inhibitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Influenza RNA Polymerase Inhibitor Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Influenza RNA Polymerase Inhibitor Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Influenza RNA Polymerase Inhibitor Market Size Market Share by Country (2021-2026)
Table 23. Americas Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
Table 25. Americas Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)
Table 27. APAC Influenza RNA Polymerase Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Influenza RNA Polymerase Inhibitor Market Size Market Share by Region (2021-2026)
Table 29. APAC Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Influenza RNA Polymerase Inhibitor Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Influenza RNA Polymerase Inhibitor Market Size Market Share by Country (2021-2026)
Table 33. Europe Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Influenza RNA Polymerase Inhibitor
Table 39. Key Market Challenges & Risks of Influenza RNA Polymerase Inhibitor
Table 40. Key Industry Trends of Influenza RNA Polymerase Inhibitor
Table 41. Global Influenza RNA Polymerase Inhibitor Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Influenza RNA Polymerase Inhibitor Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Influenza RNA Polymerase Inhibitor Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Influenza RNA Polymerase Inhibitor Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AstraZeneca Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 46. AstraZeneca Influenza RNA Polymerase Inhibitor Product Offered
Table 47. AstraZeneca Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. Tesaro Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 51. Tesaro Influenza RNA Polymerase Inhibitor Product Offered
Table 52. Tesaro Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Tesaro Main Business
Table 54. Tesaro Latest Developments
Table 55. Merck & Co Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 56. Merck & Co Influenza RNA Polymerase Inhibitor Product Offered
Table 57. Merck & Co Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Merck & Co Main Business
Table 59. Merck & Co Latest Developments
Table 60. Clovis Oncology Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 61. Clovis Oncology Influenza RNA Polymerase Inhibitor Product Offered
Table 62. Clovis Oncology Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Clovis Oncology Main Business
Table 64. Clovis Oncology Latest Developments
Table 65. Pfizer Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 66. Pfizer Influenza RNA Polymerase Inhibitor Product Offered
Table 67. Pfizer Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Pfizer Main Business
Table 69. Pfizer Latest Developments
Table 70. GSK Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 71. GSK Influenza RNA Polymerase Inhibitor Product Offered
Table 72. GSK Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. GSK Main Business
Table 74. GSK Latest Developments
Table 75. Zai Lab Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 76. Zai Lab Influenza RNA Polymerase Inhibitor Product Offered
Table 77. Zai Lab Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Zai Lab Main Business
Table 79. Zai Lab Latest Developments
Table 80. Fujifilm Pharma Details, Company Type, Influenza RNA Polymerase Inhibitor Area Served and Its Competitors
Table 81. Fujifilm Pharma Influenza RNA Polymerase Inhibitor Product Offered
Table 82. Fujifilm Pharma Influenza RNA Polymerase Inhibitor Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Fujifilm Pharma Main Business
Table 84. Fujifilm Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Influenza RNA Polymerase Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Influenza RNA Polymerase Inhibitor Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Influenza RNA Polymerase Inhibitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Influenza RNA Polymerase Inhibitor Sales Market Share by Country/Region (2025)
Figure 8. Influenza RNA Polymerase Inhibitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Type in 2025
Figure 10. Influenza RNA Polymerase Inhibitor in Pharmaceutical Manufacturing
Figure 11. Global Influenza RNA Polymerase Inhibitor Market: Pharmaceutical Manufacturing (2021-2026) & ($ millions)
Figure 12. Influenza RNA Polymerase Inhibitor in Clinical Research
Figure 13. Global Influenza RNA Polymerase Inhibitor Market: Clinical Research (2021-2026) & ($ millions)
Figure 14. Influenza RNA Polymerase Inhibitor in Others
Figure 15. Global Influenza RNA Polymerase Inhibitor Market: Others (2021-2026) & ($ millions)
Figure 16. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Application in 2025
Figure 17. Global Influenza RNA Polymerase Inhibitor Revenue Market Share by Player in 2025
Figure 18. Global Influenza RNA Polymerase Inhibitor Market Size Market Share by Region (2021-2026)
Figure 19. Americas Influenza RNA Polymerase Inhibitor Market Size 2021-2026 ($ millions)
Figure 20. APAC Influenza RNA Polymerase Inhibitor Market Size 2021-2026 ($ millions)
Figure 21. Europe Influenza RNA Polymerase Inhibitor Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size 2021-2026 ($ millions)
Figure 23. Americas Influenza RNA Polymerase Inhibitor Value Market Share by Country in 2025
Figure 24. United States Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Influenza RNA Polymerase Inhibitor Market Size Market Share by Region in 2025
Figure 29. APAC Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
Figure 30. APAC Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)
Figure 31. China Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 35. India Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Influenza RNA Polymerase Inhibitor Market Size Market Share by Country in 2025
Figure 38. Europe Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
Figure 39. Europe Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)
Figure 40. Germany Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 41. France Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Influenza RNA Polymerase Inhibitor Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 54. APAC Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 55. Europe Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 57. United States Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 58. Canada Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 59. Mexico Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 60. Brazil Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 61. China Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 62. Japan Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 63. Korea Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 65. India Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 66. Australia Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 67. Germany Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 68. France Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 69. UK Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 70. Italy Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 71. Russia Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 72. Egypt Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 73. South Africa Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 74. Israel Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 75. Turkey Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)
Figure 76. Global Influenza RNA Polymerase Inhibitor Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Influenza RNA Polymerase Inhibitor Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Influenza RNA Polymerase Inhibitor Market Size 2027-2032 ($ millions)